News on ImmunoGen from BioPortfolio.com http://www.BioPortfolio.com Consolidated ImmunoGen news from BioPortfolio.com Wed, 10 Feb 2010 15:39:33 GMT en Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response In Clinical Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040364&HITNO=0&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040364&THISHREF=http://c.moreover.com/click/here.pl%3fz2538710449%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4040364&HITNO=0&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4040364&THISHREF=http://c.moreover.com/click/here.pl%3fz2538710449%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comMedical News Today: Inovio Biomedica Reports Interim Data on Its Cervical Cancer Therapeutic Vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039910&HITNO=1&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039910&THISHREF=http://c.moreover.com/click/here.pl%3fz2538463981%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039910&HITNO=1&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039910&THISHREF=http://c.moreover.com/click/here.pl%3fz2538463981%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTradingMarkets: Flu Vaccines: Study data from Sanofi Pasteur update knowledge of flu vaccineshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041188&HITNO=2&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041188&THISHREF=http://c.moreover.com/click/here.pl%3fz2539026192%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041188&HITNO=2&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041188&THISHREF=http://c.moreover.com/click/here.pl%3fz2539026192%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNewsRX: Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Antibodhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039974&HITNO=3&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039974&THISHREF=http://c.moreover.com/click/here.pl%3fz2538504112%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039974&HITNO=3&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039974&THISHREF=http://c.moreover.com/click/here.pl%3fz2538504112%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: ::: Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Anthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039411&HITNO=4&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039411&THISHREF=http://c.moreover.com/click/here.pl%3fz2538102489%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039411&HITNO=4&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039411&THISHREF=http://c.moreover.com/click/here.pl%3fz2538102489%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBiotech Intelligence: Medical News: Inovio Biomedical Cervical Cancer Therapeutic Vaccine Generates Dose-Related Immune Response In Clinical Trialhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041370&HITNO=5&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041370&THISHREF=http://c.moreover.com/click/here.pl%3fz2539090270%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4041370&HITNO=5&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4041370&THISHREF=http://c.moreover.com/click/here.pl%3fz2539090270%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comBioFind: Inovio Biomedica Reports Interim Data on Its Cervical Cancer Therapeutic Vaccinehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039917&HITNO=6&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039917&THISHREF=http://c.moreover.com/click/here.pl%3fz2538470344%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039917&HITNO=6&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039917&THISHREF=http://c.moreover.com/click/here.pl%3fz2538470344%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: A Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of rhuMAb Beta7 in Patients With Ulcerative Colitishttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038470&HITNO=7&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038470&THISHREF=http://c.moreover.com/click/here.pl%3fz2537620841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038470&HITNO=7&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038470&THISHREF=http://c.moreover.com/click/here.pl%3fz2537620841%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comSmartBrief: Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Antibodhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037551&HITNO=8&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037551&THISHREF=http://c.moreover.com/click/here.pl%3fz2537139603%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037551&HITNO=8&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037551&THISHREF=http://c.moreover.com/click/here.pl%3fz2537139603%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharma Live: Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Antibodhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037236&HITNO=9&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037236&THISHREF=http://c.moreover.com/click/here.pl%3fz2536986301%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037236&HITNO=9&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037236&THISHREF=http://c.moreover.com/click/here.pl%3fz2536986301%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEON: Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Antibodyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037127&HITNO=10&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037127&THISHREF=http://c.moreover.com/click/here.pl%3fz2536913311%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037127&HITNO=10&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037127&THISHREF=http://c.moreover.com/click/here.pl%3fz2536913311%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novelhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037072&HITNO=11&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037072&THISHREF=http://c.moreover.com/click/here.pl%3fz2536893341%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037072&HITNO=11&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037072&THISHREF=http://c.moreover.com/click/here.pl%3fz2536893341%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comForbes.com: Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Antibodyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036871&HITNO=12&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036871&THISHREF=http://c.moreover.com/click/here.pl%3fz2536808928%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036871&HITNO=12&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036871&THISHREF=http://c.moreover.com/click/here.pl%3fz2536808928%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comEarthtimes.org: Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Antibodyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036855&HITNO=13&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036855&THISHREF=http://c.moreover.com/click/here.pl%3fz2536793045%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036855&HITNO=13&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036855&THISHREF=http://c.moreover.com/click/here.pl%3fz2536793045%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comStreet Insider: Phase I Trial Commences Treating Patients with Pancreatic and Colorectal Cancer Using Novel Monoclonal Antibodyhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036854&HITNO=14&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036854&THISHREF=http://c.moreover.com/click/here.pl%3fz2536792142%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036854&HITNO=14&MSIZE=314&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=ImmunoGen&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036854&THISHREF=http://c.moreover.com/click/here.pl%3fz2536792142%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPR inside: